Advanced Bionutrition Corporation

Other

Intervet Inc.

Majid Keshtmand

Mordechai Harel

Trisha Rice

Andrew Xian Chen

Hailiang Chen

Mohammed Abdul Rahman

Swetha Kambalapally

Sally A Look

Sara Morrison-Rowe

James Cecil Free

Swetha Kamballapally

A dry stable probiotic composition is provided. The composition comprises one or more viable probiotic microorganisms, one or more hydrolyzed proteins, one or more disaccharides, one or more oligosaccharides, and one or more polysaccharides, but not trehalose. The composition has viability of at least 1&#xd7;10CFU/g, and a viability loss of less than 1 log unit/g after 3 months at a temperature of 40&#xb0; C. and a relative humidity of 33%. Also provided are methods for preparing the dry stable probiotic composition.

Stable dry probiotic compositions for special dietary uses

A dry stable composition is provided. The composition comprises one or more viable microorganisms, at least 50% by weight of one or more hydrolyzed proteins and less than 10% by weight of one or more sugars selected from the group consisting of monosaccharides, disaccharides and combinations thereof, each weight percentage based on the total weight of the dry composition. Preferably, the composition comprises no monosaccharide or disaccharide. The composition may further comprise one or more oligosaccharides, one or more polysaccharides, one or more carboxylic acid salts, or a combination thereof. The composition may have viability of at least 1&#xd7;10CFU/g, and a viability loss of less than 1 log unit/g after 84 days at a temperature of 40&#xb0; C. and a relative humidity of 33%. Also provided are methods for preparing the dry stable composition.

Stable dry compositions having no or little sugars

A composition comprising hydrophobic droplets coated by a shell and dispersed in a matrix and a consumable product comprising the composition are provided. The hydrophobic droplets comprise a hydrophobic compound, the shell comprises an irreversibly denatured protein, and the matrix comprises a protein, a starch, and a polysaccharide. Also provided are methods for preparing the composition and the consumable product.

Encapsulation of hydrophobic biologically active compounds

Provided are methods for reducing the excipient load of pharmaceutical formulations containing 3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathiin 10,10-dioxide as the active pharmaceutical ingredient, and compositions related thereto. In particular, provided is a pharmaceutical product comprising 3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathiin 10,10-dioxide and a stabilizer admixed throughout a solid-form unilamellar matrix, wherein the ratio of 3-fluoro-7-(2,2,2-trifluoroethoxy)phenoxathiin 10,10-dioxide to stabilizer ranges from about 2:3 to about 1:10, and related methods of forming the pharmaceutical product.

Oral antidepressant formulation with reduced excipient load

Growing community of inventors

Baltimore, MD, United States of America

Majid Keshtmand